Apr. 26, 2023 Existing Drugs Prevent Alzheimer’s Disease-Related Cognitive Impairment in Mice, New Research at The Lewis Katz School of Medicine at Temple University Shows By Katz CommunicationsChanges in blood vessels in the brain linked to the build-up of a sticky protein known as amyloid […] Sep. 21, 2022 First Individual Treated with CRISPR-Based HIV Therapy, a Breakthrough Treatment Pioneered by Researchers at Lewis Katz School of Medicine at Temple University and Developed by Excision BioTherapeutics By Katz CommunicationsIn a major milestone in the search for a cure for HIV/AIDS, a breakthrough gene-editing therapy for […] Jul. 13, 2022 New $4M NIH Grant Awarded to Researchers at Lewis Katz School of Medicine to Fund Groundbreaking Research on Disparities in Hepatitis B and Liver Disease in Asian-Americans By Katz CommunicationsAmong the 2.4 million Americans living with chronic hepatitis B virus (HBV), Asian-Americans are […] Feb. 24, 2022 First Clinical Trial of CRISPR-Based HIV Therapy Founded on Breakthrough Research at Lewis Katz School of Medicine By Katz CommunicationsThe first clinical trial of a gene-editing therapy for human immunodeficiency virus type 1 (HIV) […] Sep. 15, 2021 Groundbreaking Research at Temple Paves Way for First Trial of CRISPR-Based HIV Therapy in Human Patients By Katz Communications For the last seven years, researchers at the Lewis Katz School of Medicine at Temple University […] Aug. 28, 2021 Faculty Spotlight: Beata Kosmider, PhD By Katz CommunicationsBeata Kosmider, PhD, Associate Professor of Microbiology, Immunology, and Inflammation at the Lewis […] Aug. 13, 2021 Fels and Fox Chase Researchers Highlight Roles of TET2 and DNMT3A Mutations in Personalized Medicine-Guided Synthetic Lethality Against Leukemia By Katz CommunicationsIn a recent study published in Cancer Research, researchers from Fels Cancer Institute for […] May 24, 2021 Lewis Katz School of Medicine’s Center for Urban Bioethics Receives $1 Million Legacy Bequest and $50,000 Donation from Dr. Margaret Barnes By Katz CommunicationsBy the time Margaret M. Barnes arrived at Temple University’s medical school in 1977, she had […] Feb. 18, 2021 Excision BioTherapeutics Secures $60 Million to Advance CRISPR-Based Gene Editing Constructs Developed at Temple into Clinical Trial for People Living with Chronic HIV Infection By Katz Communications Excision BioTherapeutics, Inc. (Excision) has secured $60 million in investor financing to advance […] Dec. 10, 2020 New $2.5 Million NIDDK Grant Gives Temple Researchers Opportunity to Advance Tools to Predict Hospital Readmission Among Patients with Diabetes By Katz CommunicationsEach year in the United States, more than 1 million patients with diabetes make return trips to the […] Jul. 22, 2020 Temple Receives $5 Million Gift from Dr. Gerald M. Lemole and Emily Jane Lemole to Establish The Lemole Center for Integrated Lymphatics and Vascular Research By Katz CommunicationsGerald M. Lemole, MD, a 1962 graduate of the Lewis Katz School of Medicine at Temple University […] Jul. 2, 2019 HIV Eliminated from the Genomes of Living Animals By Katz Communications In a major collaborative effort, researchers at the Lewis Katz School of Medicine at Temple […]
Apr. 26, 2023 Existing Drugs Prevent Alzheimer’s Disease-Related Cognitive Impairment in Mice, New Research at The Lewis Katz School of Medicine at Temple University Shows By Katz CommunicationsChanges in blood vessels in the brain linked to the build-up of a sticky protein known as amyloid […] Sep. 21, 2022 First Individual Treated with CRISPR-Based HIV Therapy, a Breakthrough Treatment Pioneered by Researchers at Lewis Katz School of Medicine at Temple University and Developed by Excision BioTherapeutics By Katz CommunicationsIn a major milestone in the search for a cure for HIV/AIDS, a breakthrough gene-editing therapy for […] Jul. 13, 2022 New $4M NIH Grant Awarded to Researchers at Lewis Katz School of Medicine to Fund Groundbreaking Research on Disparities in Hepatitis B and Liver Disease in Asian-Americans By Katz CommunicationsAmong the 2.4 million Americans living with chronic hepatitis B virus (HBV), Asian-Americans are […] Feb. 24, 2022 First Clinical Trial of CRISPR-Based HIV Therapy Founded on Breakthrough Research at Lewis Katz School of Medicine By Katz CommunicationsThe first clinical trial of a gene-editing therapy for human immunodeficiency virus type 1 (HIV) […] Sep. 15, 2021 Groundbreaking Research at Temple Paves Way for First Trial of CRISPR-Based HIV Therapy in Human Patients By Katz Communications For the last seven years, researchers at the Lewis Katz School of Medicine at Temple University […] Aug. 28, 2021 Faculty Spotlight: Beata Kosmider, PhD By Katz CommunicationsBeata Kosmider, PhD, Associate Professor of Microbiology, Immunology, and Inflammation at the Lewis […] Aug. 13, 2021 Fels and Fox Chase Researchers Highlight Roles of TET2 and DNMT3A Mutations in Personalized Medicine-Guided Synthetic Lethality Against Leukemia By Katz CommunicationsIn a recent study published in Cancer Research, researchers from Fels Cancer Institute for […] May 24, 2021 Lewis Katz School of Medicine’s Center for Urban Bioethics Receives $1 Million Legacy Bequest and $50,000 Donation from Dr. Margaret Barnes By Katz CommunicationsBy the time Margaret M. Barnes arrived at Temple University’s medical school in 1977, she had […] Feb. 18, 2021 Excision BioTherapeutics Secures $60 Million to Advance CRISPR-Based Gene Editing Constructs Developed at Temple into Clinical Trial for People Living with Chronic HIV Infection By Katz Communications Excision BioTherapeutics, Inc. (Excision) has secured $60 million in investor financing to advance […] Dec. 10, 2020 New $2.5 Million NIDDK Grant Gives Temple Researchers Opportunity to Advance Tools to Predict Hospital Readmission Among Patients with Diabetes By Katz CommunicationsEach year in the United States, more than 1 million patients with diabetes make return trips to the […] Jul. 22, 2020 Temple Receives $5 Million Gift from Dr. Gerald M. Lemole and Emily Jane Lemole to Establish The Lemole Center for Integrated Lymphatics and Vascular Research By Katz CommunicationsGerald M. Lemole, MD, a 1962 graduate of the Lewis Katz School of Medicine at Temple University […] Jul. 2, 2019 HIV Eliminated from the Genomes of Living Animals By Katz Communications In a major collaborative effort, researchers at the Lewis Katz School of Medicine at Temple […]
